Robert F. Kennedy Jr. & GSK plc
7 shared events · Importance 3 · Last updated Aug 13, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
Robert F. Kennedy Jr.: As HHS Secretary, he championed the vaccine overhaul and has promoted debunked autism claims. His leadership is central to the policy, but he faces legal challenges and professional condemnation.
GSK plc: Another vaccine manufacturer, it also criticized the order and faces potential business implications if separate vaccines are developed.
Aug 10, 2026 · 235 articles
Regulatory
Robert F. Kennedy Jr.: Kennedy's skepticism of mRNA vaccines influenced funding cuts and regulatory scrutiny, but the approval proceeded despite his opposition.
GSK plc: GSK plc's flu vaccines face potential competition from mFLUSIVA.
Aug 05, 2026 · 105 articles
Domestic
Robert F. Kennedy Jr.: Robert F. Kennedy Jr., as Health and Human Services Secretary, led the administration's autism initiative and promoted discredited theories linking vaccines to autism.
GSK plc: GSK plc, as the manufacturer of Wellcovorin (a branded version of leucovorin), was asked by the United States — Food and Drug Administration to file a new application with data on cerebral folate deficiency.
Sep 22, 2025 · 6 articles
Domestic
GSK plc: GSK plc, a hepatitis B vaccine maker, defended its products as safe, and its shares finished 0.3% lower.
Dec 05, 2025 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Robert F. Kennedy Jr. and GSK plc interact across events, view sentiment trends, and discover connected entities.
Open Dashboard